Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial
呋喹替尼联合信迪利单抗治疗错配修复功能正常的晚期子宫内膜癌患者:一项多中心、单臂、Ib/II期试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-67375-3
Wu, Xiaohua; Wang, Jing; Wang, Danbo; Li, Guiling; Zhang, Jieqing; Chen, Hongmin; Yang, Hongying; Zhou, Qi; Wang, Ke; Wu, Yumei; Yi, Tienan; Liu, Jihong; Huang, Yi; Bai, Yuxian; Wang, Keming; Jiang, Kui; Lou, Hanmei; An, Ruifang; Li, Xiumin; Pan, Yueyin; Wang, Yue; Tao, Weiping; Song, Kun; Kang, Yu; Li, Yuzhi; Shi, Wenyu; Liu, Anwen; Yang, Ying; Wang, Yijun; Chen, Keyan; Shi, Haiyan; Lu, Puhan; Tan, Panfeng; Fan, Songhua; Shi, Michael; Su, Weiguo